859
Views
17
CrossRef citations to date
0
Altmetric
Reviews

Emerging therapeutic interventions for idiopathic pulmonary fibrosis

, PhD, , PhD, , PhD, , PhD & , PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jinqing Hu, Dewei Shang, Xinwen Xu, Xiuling He, Xiaojia Ni, Ming Zhang, Zhanzhang Wang, Chang Qiu, Shuhua Deng, Haoyang Lu, Xiuqing Zhu, Wencan Huang & Yuguan Wen. (2016) Effect of grapefruit juice and food on the pharmacokinetics of pirfenidone in healthy Chinese volunteers: a diet–drug interaction study. Xenobiotica 46:6, pages 516-521.
Read now

Articles from other publishers (16)

Yani Wang, Siqi Hu, Lisha Shen, Song Liu, Linyan Wan, Shuhui Yang, Mengjie Hou, Xinlun Tian, Hongbing Zhang & Kai-Feng Xu. (2021) Dynamic Observation of Autophagy and Transcriptome Profiles in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis. Frontiers in Molecular Biosciences 8.
Crossref
Giuseppe Campiani, Caterina Cavella, Jeremy D. Osko, Margherita Brindisi, Nicola Relitti, Simone Brogi, A. Prasanth Saraswati, Stefano Federico, Giulia Chemi, Samuele Maramai, Gabriele Carullo, Benedikt Jaeger, Alfonso Carleo, Rosaria Benedetti, Federica Sarno, Stefania Lamponi, Paola Rottoli, Elena Bargagli, Carlo Bertucci, Daniele Tedesco, Daniel Herp, Johanna Senger, Giovina Ruberti, Fulvio Saccoccia, Simona Saponara, Beatrice Gorelli, Massimo Valoti, Breándan Kennedy, Husvinee Sundaramurthi, Stefania Butini, Manfred Jung, Katy M. RoachLucia Altucci, Peter BraddingDavid W. Christianson, Sandra Gemma & Antje Prasse. (2021) Harnessing the Role of HDAC6 in Idiopathic Pulmonary Fibrosis: Design, Synthesis, Structural Analysis, and Biological Evaluation of Potent Inhibitors. Journal of Medicinal Chemistry 64:14, pages 9960-9988.
Crossref
Runfeng Lin, Zheng Zhang, Shengtian Cao, Wen Yang, Yinglin Zuo, Xinye Yang, Jiancun Zhang, Juan Xu, Jing Li & Xiaojun Wang. (2021) The development of HEC-866 and its analogues for the treatment of idiopathic pulmonary fibrosis. RSC Medicinal Chemistry 12:7, pages 1222-1231.
Crossref
Giovanni Forte, Beatrice Bocca, Andrea Pisano, Claudia Collu, Cristiano Farace, Angela Sabalic, Marta Senofonte, Alessandro Giuseppe Fois, Vittorio Lorenzo Mazzarello, Pietro Pirina & Roberto Madeddu. (2021) The levels of trace elements in sputum as biomarkers for idiopathic pulmonary fibrosis. Chemosphere 271, pages 129514.
Crossref
Pauline T. Lukey, Christopher Coello, Roger Gunn, Christine Parker, Frederick J. Wilson, Azeem Saleem, Nadia Garman, Maria Costa, Stuart Kendrick, Mayca Onega, Arthur R. Kang’ombe, Allan Listanco, James Davies, Joaquim Ramada-Magalhaes, Sara Moz, William A. Fahy, Toby M. Maher, Gisli Jenkins, Jan Passchier & Richard P. Marshall. (2019) Clinical quantification of the integrin αvβ6 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study). European Journal of Nuclear Medicine and Molecular Imaging 47:4, pages 967-979.
Crossref
Songwen Lin, Jing Jin, Ying Liu, Hua Tian, Yan Zhang, Rong Fu, Jingbo Zhang, Mingjin Wang, Tingting Du, Ming Ji, Deyu Wu, Kehui Zhang, Li Sheng, Yan Li, Xiaoguang Chen & Heng Xu. (2019) Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. Journal of Medicinal Chemistry 62:19, pages 8873-8879.
Crossref
João Q. Coentro, Eugenia Pugliese, Geoffrey Hanley, Michael Raghunath & Dimitrios I. Zeugolis. (2019) Current and upcoming therapies to modulate skin scarring and fibrosis. Advanced Drug Delivery Reviews 146, pages 37-59.
Crossref
Beatriz Ballester, Javier Milara & Julio Cortijo. (2019) Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets. International Journal of Molecular Sciences 20:3, pages 593.
Crossref
Alessandro Pini, Roberta Verta, Cristina Grange, Maura Gurrieri & Arianna Carolina Rosa. (2019) Histamine and diabetic nephropathy: an up-to-date overview. Clinical Science 133:1, pages 41-54.
Crossref
Alessandro G. Fois, Panagiotis Paliogiannis, Salvatore Sotgia, Arduino A. Mangoni, Elisabetta Zinellu, Pietro Pirina, Ciriaco Carru & Angelo Zinellu. (2018) Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review. Respiratory Research 19:1.
Crossref
Juanjuan Shou, Jingjing Cao, Shanshan Zhang, Ruicong Sun, Mengmeng Zhao, Keqiang Chen, Shao Bo Su, Jianhua Yang & Tianshu Yang. (2018) SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice. Biochemical and Biophysical Research Communications 503:2, pages 757-762.
Crossref
Gwenda F. Vasse, Philipp T. Kühn, Qihui Zhou, Shardul A. Bhusari, Catharina Reker-Smit, Barbro N. Melgert & Patrick van Rijn. (2018) Collagen morphology influences macrophage shape and marker expression in vitro. Journal of Immunology and Regenerative Medicine 1, pages 13-20.
Crossref
Yi-Min Liu, Kunal Nepali & Jing-Ping Liou. (2016) Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. Journal of Medicinal Chemistry 60:2, pages 527-553.
Crossref
Xiang Huang, Weicheng Wang, Huaqin Yuan, Jing Sun, Lele Li, Xingxin Wu, Jinhua Luo & Yanhong Gu. (2016) Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. The Tohoku Journal of Experimental Medicine 239:4, pages 251-261.
Crossref
Mario C. Manresa, Catherine Godson & Cormac T. Taylor. (2014) Hypoxia-sensitive pathways in inflammation-driven fibrosis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307:12, pages R1369-R1380.
Crossref
Sandeep K. Agarwal. (2014) Integrins and cadherins as therapeutic targets in fibrosis. Frontiers in Pharmacology 5.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.